NIPRIDE RTU (EXELA PHARMA SCIENCES, LLC)


Welcome to the PulseAid listing for the NIPRIDE RTU drug offered from EXELA PHARMA SCIENCES, LLC. This Vasodilation [PE],Vasodilator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: EXELA PHARMA SCIENCES, LLC
NON-PROPRIETARY NAME: Sodium Nitroprusside
SUBSTANCE NAME: SODIUM NITROPRUSSIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Vasodilation [PE],Vasodilator [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-03-20
END MARKETING DATE: 0000-00-00


NIPRIDE RTU HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNIPRIDE RTU from EXELA PHARMA SCIENCES, LLC
LABELER NAME: EXELA PHARMA SCIENCES, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 0.5(mg/mL)
START MARKETING DATE: 2017-03-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51754-1006_0c46c9d4-9923-4cd2-8e83-9228120bb93d
PRODUCT NDC: 51754-1006
APPLICATION NUMBER: NDA209387

Other SODIUM NITROPRUSSIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Sodium Nitroprusside
EXELA PHARMA SCIENCES, LLCNIPRIDE RTU
Nexus Pharmaceuticals IncSodium Nitroprusside
Sagent PharmaceuticalsSodium Nitroprusside
Valeant Pharmaceuticals North America LLCNitropress